Synta to Present at the Lazard Capital Markets 9thAnnual Healthcare Conference
LEXINGTON, Mass.--(BUSINESS WIRE)-- Synta Pharmaceuticals Corp. (NAS: SNTA) today announced that the Company will present at the Lazard Capital Markets 9th Annual Healthcare Conference on Wednesday, November 14 at 10:30 a.m. (EST) in New York.
A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, www.syntapharma.com.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit www.syntapharma.com.
Synta Pharmaceuticals Corp.
George Farmer, 781-541-7125
KEYWORDS: United States North America Massachusetts New York
The article Synta to Present at the Lazard Capital Markets 9th Annual Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.